Condition: Obsessive-Compulsive Disorder · Sponsor: Severance Hospital
The purpose of this study is to determine whether pharmaco(epi)genetic study predict selective serotonin reuptake inhibitor (SSRI) responsiveness in advance before the appearance of the drug effect until 4 months(16 weeks), 6 months, and 1 year after administration of SSRIs.
This description comes directly from the study's public registry record.
Se Joo Kim, M.D. · +82-2-2228-1627 · kimsejoo@yuhs.ac
Jee In Kang, M.D. · +82-2-2228-1630 · jeeinkang@yuhs.ac
Always discuss trial participation with your own doctor first.
| Yonsei Univ. Health System Severance Hospital | Seoul, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02431845